Skip to content

Quick ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
1.2×-0.2×
Danaher logo
DanaherDHR
1.5×+0.5×
Repligen logo
RepligenRGEN
7.8×+2.0×
ADMA Biologics logo
ADMA BiologicsADMA
3.9×+0.6×
Revvity logo
RevvityRVTY
1.4×-1.6×
TEC
Bio-TechneTECH
3.2×+0.6×

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s quick ratio?
Maravai LifeSciences Holdings, Inc. (MRVI) reported quick ratio of 5× in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s quick ratio changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s quick ratio decreased by 4.1% year-over-year, from 5.2× to 5×.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s quick ratio has grown at a 20.1% compound annual growth rate (CAGR), from 2.3× to 5.7×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.